74 results
8-K
EX-99.1
SLNO
Soleno Therapeutics Inc
21 Apr 16
Capnia Names Rajen Dalal to Board of Directors
12:00am
for sale in the U.S. and has received CE Mark certification for sale in the European Union. CoSense is used for the monitoring of CO from internal … . and European Union. The Company’s commercial, neonatology-focused product line also includes innovative pulmonary resuscitation solutions, including
8-K
EX-99.1
SLNO
Soleno Therapeutics Inc
27 Jul 15
Capnia Announces $10 Million At-the-Market Firm Commitment Stock Purchase Agreement with Aspire Capital
12:00am
breath. CoSense has 510(k) clearance for sale in the U.S. and has received CE Mark certification for sale in the European Union. CoSense is used … approximately three million births in the U.S. and European Union. Capnia’s proprietary therapeutic technology uses nasal, non-inhaled CO2 and is being
8-K
EX-99.1
SLNO
Soleno Therapeutics Inc
5 Mar 15
Capnia Announces Receipt of $3.6 million From Series B Warrant Exercise and Issuance of Series C Warrants
12:00am
in the U.S. CoSense has also received CE Mark certification for sale in the European Union. Capnia’s proprietary therapeutic technology, currently under
424B3
SLNO
Soleno Therapeutics Inc
14 Oct 15
Prospectus supplement
12:00am
for sale in the U.S. and has received CE Mark certification for sale in the European Union. CoSense is used for the monitoring of CO from internal … in the U.S. and European Union. Capnia’s proprietary therapeutic technology uses nasal, non-inhaled CO2 and is being evaluated to treat the symptoms
8-K
EX-1.1
ltyif3lk 3vprajtz
29 Sep 23
Entry into a Material Definitive Agreement
4:55pm
8-K
EX-1.1
70bkucac3etx3o ji03
7 May 24
Soleno Therapeutics Announces Pricing of Approximately $138 Million Public Offering of Common Stock
5:28pm